Cargando…
Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data
BACKGROUND: Treating cancer depends in part on identifying the mutations driving each patient’s disease. Many clinical laboratories are adopting high-throughput sequencing for assaying patients’ tumours, applying targeted panels to formalin-fixed paraffin-embedded tumour tissues to detect clinically...
Autores principales: | Karimnezhad, Ali, Palidwor, Gareth A., Thavorn, Kednapa, Stewart, David J., Campbell, Pearl A., Lo, Bryan, Perkins, Theodore J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560075/ https://www.ncbi.nlm.nih.gov/pubmed/33059707 http://dx.doi.org/10.1186/s12920-020-00803-z |
Ejemplares similares
-
Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study
por: Kumar, Srishti, et al.
Publicado: (2022) -
A General Model of Codon Bias Due to GC Mutational Bias
por: Palidwor, Gareth A., et al.
Publicado: (2010) -
Somatic Point Mutation Calling in Low Cellularity Tumors
por: Kassahn, Karin S., et al.
Publicado: (2013) -
BIDCHIPS: bias decomposition and removal from ChIP-seq data clarifies true binding signal and its functional correlates
por: Ramachandran, Parameswaran, et al.
Publicado: (2015) -
MaSC: mappability-sensitive cross-correlation for estimating mean fragment length of single-end short-read sequencing data
por: Ramachandran, Parameswaran, et al.
Publicado: (2013)